Literature DB >> 16378223

Apoptosis in the pathogenesis of cholesteatoma in adults.

Ewa Olszewska1, Stanislaw Chodynicki, Lech Chyczewski.   

Abstract

The aim of this study was to determine the distribution and apoptotic capacity in the various layers of cholesteatoma epithelium compared to the normal skin. Cholesteatomas were collected during surgical procedures of the ear. Normal skin specimens taken from the retroauricular area served as controls. Apoptosis was detected by using highly specific antibodies against APO2.7 antigen. The Membstain Apoptosis kit Direct based on in situ labeling of nuclear DNA fragmentation (Tolt-mediated dUTP nick and labeling TUNEL staining) was used. The distribution of apoptotic cells in the layer of the cholesteatoma epithelium and the epidermis was determined. The percentage of apoptotic cells was then counted per 100 cells of cholesteatoma epithelium and the normal epidermis in three different areas of each section and expressed in terms of mean +/- SD. An automatic analyzing system was used for counting. In normal epidermis, the apoptotic cells were observed in the granular layer of the epidermis. The percentage of these cells was 28.5 +/- 8.1%. A significantly greater number of apoptotic cells was observed in the suprabasal layers of the cholesteatoma epithelium (47.39 +/- 6.2%). A statistically significant difference was obtained for APO2.7-positive cells in the cholesteatoma epithelium as compared to the skin (P < 0.05) as determined by Student's t-test and the Mann-Whitney U test. Apoptotic activity is mainly observed in the suprabasal layer of cholesteatoma epithelium. It is not seen in the basal layer. Apoptosis plays an important role in the pathogenesis of cholesteatoma. It seems to be part of the differentiation and accumulation of keratin debris within the middle ear and expansion of cholesteatoma.

Entities:  

Mesh:

Year:  2005        PMID: 16378223     DOI: 10.1007/s00405-005-1026-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

1.  Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

Authors:  J Bujia; H Sudhoff; A Holly; H Hildmann; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas.

Authors:  R Sheikholeslam-Zadeh; C Decaestecker; C Delbrouck; A Danguy; I Salmon; Y Zick; H Kaltner; S Hassid; H J Gabius; R Kiss; G Choufani
Journal:  Laryngoscope       Date:  2001-06       Impact factor: 3.325

3.  Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas.

Authors:  G Choufani; V Mahillon; C Decaestecker; T Lequeux; A Danguy; I Salmon; H J Gabius; S Hassid; R Kiss
Journal:  Laryngoscope       Date:  1999-11       Impact factor: 3.325

4.  Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear.

Authors:  S Ergün; B Carlsöö; X Zheng
Journal:  Clin Otolaryngol Allied Sci       Date:  1999-08

5.  Cholesteatoma: a morphologic study of stratum corneum lipids.

Authors:  V Svane-Knudsen; L Halkier-Sørensen; G Rasmussen; P D Ottosen
Journal:  Acta Otolaryngol       Date:  2001-07       Impact factor: 1.494

6.  Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.

Authors:  H Shinoda; C C Huang
Journal:  Laryngoscope       Date:  1995-11       Impact factor: 3.325

7.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

8.  Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma.

Authors:  H J Park; K Park
Journal:  Laryngoscope       Date:  1999-04       Impact factor: 3.325

9.  [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].

Authors:  Ewa Olszewska; Stanisław Chodynicki; Lech Chyczewski
Journal:  Otolaryngol Pol       Date:  2003

Review 10.  Apoptosis: a gene-directed programme of cell death.

Authors:  M R Alison; C E Sarraf
Journal:  J R Coll Physicians Lond       Date:  1992-01
View more
  5 in total

1.  Induction of cytokine production in cholesteatoma keratinocytes by extracellular high-mobility group box chromosomal protein 1 combined with DNA released by apoptotic cholesteatoma keratinocytes.

Authors:  Zhangcai Chi; Zhengmin Wang; Qiong Liang; Yaying Zhu; Qiang du
Journal:  Mol Cell Biochem       Date:  2014-11-23       Impact factor: 3.396

2.  Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Authors:  Miroslaw J Szczepanski; Michal Luczak; Ewa Olszewska; Marta Molinska-Glura; Mariola Zagor; Antoni Krzeski; Henryk Skarzynski; Jan Misiak; Karolina Dzaman; Mikolaj Bilusiak; Tomasz Kopec; Malgorzata Leszczynska; Henryk Witmanowski; Theresa L Whiteside
Journal:  J Mol Med (Berl)       Date:  2014-11-12       Impact factor: 4.599

3.  Evaluation of bcl-2, bax and c-erbB-2 Levels in Chronic Otitis Patients with or without Cholesteatoma.

Authors:  Özgür Işık; Turgut Karlıdağ; Bengü Çobanoğlu Şimşek; Erol Keleş; İrfan Kaygusuz; Şinasi Yalçın; İsrafil Orhan; Emrah Sapmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-06-01

4.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

Review 5.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.